Manabu Setoguchi
Kagoshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Manabu Setoguchi.
Cardiovascular Research | 2001
Yasuyuki Kamogawa; Sadatoshi Biro; Masato Maeda; Manabu Setoguchi; Tatsumi Hirakawa; Hiroki Yoshida; Chuwa Tei
OBJECTIVE Dystrophin provides mechanical reinforcement to the membranes of myocytes. Dystrophin abnormalities are known to cause cardiomyopathy and skeletal muscle disorders; however, the pathogenesis of these abnormalities remains unclear. Dystrophin-deficient skeletal muscle is vulnerable to stresses such as stretch and hypo-osmotic shock. We investigated whether the myocardium of dystrophin-deficient (mdx) mice shows increased vulnerability to acute pressure overload in vivo. METHODS AND RESULTS Abdominal aortic banding was performed in 12-week-old mdx and control mice. The aortic pressure was measured by cannulation of the right carotid artery at the time of sacrifice. Systolic pressures in mdx mice at 0, 1, 2, 7 and 14 days after aortic banding were 100 +/- 11, 119 +/- 7, 123 +/- 4, 134 +/- 11 and 130 +/- 10 mmHg, respectively. Microscopic analysis revealed focal lesions in the left ventricular wall in banded mdx mice. These lesions consisted of damaged myocytes and inflammatory cells, and also of fibrosis at a late stage. Similar lesions were not observed in non-banded or banded control mice. The proportion of areas of lesions to total left ventricular area increased over time: 1.0 +/- 0.6% in mdx mice without aortic banding (sham, n = 6), and 1.7+/-1.4% 1 day (n = 6, vs. sham, NS), 2.6 +/- 1.9% 2 days (n = 7, vs. sham, P < 0.05), 6.3+ /- 6.5% 7 days (n = 13, vs. sham, P < 0.05) and 9.9 +/- 8.3% 14 days after aortic banding (n=15, vs. sham, P < 0.01). Furthermore, linear regression analysis revealed a significant correlation between percentage of lesion area and systolic pressure in mdx mice (P < 0.05). CONCLUSION Dystrophin-deficient myocardium is more vulnerable than normal myocardium to pressure overload in vivo. This result has two clinical implications: (1) the patients with dystrophynopathy, such as the Duchenne and the Becker types of muscular dystrophy and X-linked type of dilated cardiomyopathy, who develop arterial hypertension should be treated aggressively, and (2) they should avoid stresses that elevate blood pressure.
British Journal of Pharmacology | 2010
Michihisa Jougasaki; Tomoko Ichiki; Yoko Takenoshita; Manabu Setoguchi
Background and purpose: The mechanisms of anti‐inflammatory actions of statins, 3‐hydroxy‐3‐methylglutaryl CoA (HMG‐CoA) reductase inhibitors, remain unclear. We investigated the effects of statins on interleukin (IL)‐6‐induced monocyte chemo‐attractant protein (MCP)‐1 expression and monocyte chemotaxis.
American Heart Journal | 1995
Masato Maeda; Schoichiro Nakao; Hirotaka Miyazato; Manabu Setoguchi; Schinichi Arima; Itsuro Higuchi; Mitsuhiro Osame; Akira Taira; Kunihiro Nomoto; Hitoshi Toda; Minoru Tahara; Yoshihiko Atsuschi; Hiromitsu Tanaka
Duchenne and Becker muscular dystrophy (DMD/BMD) are allelic variants caused by mutations in gene-encoding dystrophin. Abnormal expression of dystrophin in skeletal muscle has been shown to correlate with severity of disease. However, in BMD the severity of skeletal and cardiac involvement are not well correlated. We studied the immunostaining pattern of cardiac dystrophin in endomyocardial biopsy specimens from 83 patients with heart disease. Immunohistochemical assessment of dystrophin in four patients with BMD and cardiomyopathy showed a variable distributions of myocytes with continuous, discontinuous, or absent membrane immunostaining patterns. These patterns were obviously different from patterns of other heart diseases. We conclude that the discontinuous immunostaining pattern of cardiac dystrophin is characteristic of BMD and that an absent pattern may be associated with more severe cardiac dysfunction. Because genetic analysis cannot determine the correct diagnosis in 35% of DMD/BMD cases, we recommend routine examination of immunostaining patterns of dystrophin in endomyocardial biopsy specimens in patients with cardiomyopathy suspected to be the result of BMD.
American Journal of Cardiology | 1996
Kohji Itoh; Toshihiro Takenaka; Shoichiro Nakao; Manabu Setoguchi; Hiromitsu Tanaka; Tadashi Suzuki; Hitoshi Sakuraba
An immunofluorescence method was applied to detect trihexosylceramide accumulated in the cardiac tissues from a variant hemizygote and a heterozygous female with Fabry disease, the incidence of which had been suspected to be high.
Heart and Vessels | 2013
Satoshi Yoshino; Shinichi Minagoe; Bo Yu; Ippei Kosedo; Makoto Yamashita; Munesumi Ishizawa; Mihoko Kono; Manabu Setoguchi; Hitoshi Nakashima; Tatsuru Matsuoka; Shoichi Suehiro; Goichi Yotsumoto; Masafumi Yamashita; Chuwa Tei
A 68-year-old woman was admitted to our hospital because of back pain and syncope. Transthoracic echocardiography revealed pericardial effusion, a collapsed right ventricle, a giant aneurysm connected to the coronary sinus, a dilated left main trunk coronary artery, and a dilated left circumflex artery (LCx). Furthermore, there was a coronary artery fistula arising from the LCx that drained into the coronary sinus. We diagnosed cardiac tamponade due to rupture of the coronary artery fistula or giant aneurysm, and successful emergency surgery was performed. Rupture of coronary artery aneurysm or coronary artery fistula is very rare. Transthoracic two-dimensional echocardiography was very useful in our case for the diagnosis of cardiac tamponade, giant coronary aneurysm, and coronary artery fistula.
Journal of Cardiology | 2014
Hiroto Shimokawahara; Michihisa Jougasaki; Manabu Setoguchi; Tomoko Ichiki; Masahiro Sonoda; Norihito Nuruki; Hitoshi Nakashima; Toyoaki Murohara; Hirohito Tsubouchi
BACKGROUND Although vascular endothelial growth factor (VEGF) is elevated in patients with acute myocardial infarction (AMI), the clinical significance of its elevation remains unclear. The present study was designed to determine the relationship between VEGF and left ventricular dimension in patients with AMI. METHODS AND RESULTS Plasma VEGF levels were examined by enzyme-linked immunosorbent assay daily for one week and then weekly for four weeks in 38 patients with AMI (65.4 ± 1.7 years). Left ventriculography was performed at 14 days, 6 months, and 2 years after the onset of AMI. Plasma VEGF levels were significantly elevated and reached a peak on day 6. Peak plasma VEGF levels positively correlated with both end-diastolic and end-systolic volume indices at 14 days after the onset of AMI. When patients with AMI were divided into two groups according to plasma VEGF levels on admission, left ventricular volume indices were higher in the high VEGF group than in the low VEGF group at the subacute phase of AMI (14 days). These differences were no longer present in the chronic phase of AMI. CONCLUSION Plasma VEGF levels were increased in patients with AMI, and peak levels were associated with left ventricular volume indices in the subacute phase, suggesting an important role of endogenous VEGF in the left ventricular dimension in patients with AMI.
American Journal of Physiology-heart and Circulatory Physiology | 2008
Tomoko Ichiki; Michihisa Jougasaki; Manabu Setoguchi; Junichi Imamura; Hitoshi Nakashima; Tatsuru Matsuoka; Masahiro Sonoda; Kazuhiko Nakamura; Shinichi Minagoe; Chuwa Tei
Journal of Molecular and Cellular Cardiology | 1997
Hirotaka Miyazato; Sadatoshi Biro; Manabu Setoguchi; Masato Maeda; Tatsuya Tashiro; Shoichiro Nakao; Hiromitsu Tanaka
Cytoskeleton | 2003
Masato Maeda; Sadatoshi Biro; Yasuyuki Kamogawa; Tatsumi Hirakawa; Manabu Setoguchi; Chuwa Tei
Journal of Cardiology | 2007
Tomoko Ichiki; Michihisa Jougasaki; Manabu Setoguchi; Hiroto Shimokawahara; Hitoshi Nakashima; Tatsuru Matsuoka; Masahiro Sonoda; Kazuhiko Nakamura; Shinichi Minagoe; Chuwa Tei